STAT+: Roche continues to look to China for new drugs
China's Hansoh Pharmaceutical Group has announced that it struck a massive deal with Roche to develop a portfolio of antibody-drug conjugates.
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by STAT News; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.
Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.
No questions yet. Be the first.
Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.
Related stories
Why it mattersA bipartisan group of lawmakers is urging the FDA to plug a loophole used to import knockoff retatrutide, an investigational obesity drug made by Eli Lilly.
By Chella·10m ago
Why it mattersHow do voters feel about trans students participating in school sports teams? Or abortion access?
How do voters feel about trans students participating in school sports teams? Or abortion access? The U.S. is about to find out.
By Chella·4h ago
Why it mattersThe median net price for 202 newly launched medicines rose by 35%, to $257,000 last year from $173,000 in 2022.
By Chella·6h ago